## HBR / Magazine Article / Lean Strategy Making

solution to close the gap. If the gap stems from a fundamental market

change or regulatory shift, the responsible executive may suggest

adding a new issue to Amgen’s prioritized agenda so that the team can

reassess the company’s position, develop new alternatives, and revise

its strategy as needed.

Amgen’s performance dialogues also highlight successes. Each session

dedicates time to exploring the causes of overperformance. For

example, after observing higher-than-expected trial enrollment for a